您当前的位置:
(+)-顺-地尔硫卓盐酸盐. (Synonyms: 盐酸地尔硫卓; CRD-401)
目录号: PC21354 纯度: ≥98%
CAS No. :33286-22-5
商品编号 规格 价格 会员价 是否有货 数量
PC21354-5g 5g 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
(+)-顺-地尔硫卓盐酸盐.
中文别名
盐酸地尔硫卓;顺-(+)-5-[(2-二甲氨基)乙基]-2-(4-甲氧基苯基)-3-乙酰氧基-2,3-二氢-1,5-苯并硫氮杂卓-4(5H)-酮盐酸盐;地尔硫;地尔硫卓;硫氮卓酮;恬尔心;硫氮酮;硫氮卓酮盐酸盐;顺-(+)-5-[(2-二甲氨基)乙基]-2-(4-甲氧基苯基)-3-乙酰氧基-2,3-二氢-1,5-苯并硫氮杂卓-4(5H)酮盐酸盐;盐酸地尔硫草;(+)-顺-地尔硫卓盐酸盐;(+)-cis-Diltiazem Hydrochloride (+)-顺-地尔硫卓盐酸盐;地尔硫卓-D5盐酸;地尔硫卓系统适应性 EP标准品;地尔硫卓盐酸盐;地尔硫卓杂质;盐酸地尔硫;盐酸地尔硫卓 EP标准品;盐酸地尔硫卓 USP标准品;盐酸地尔硫卓 标准品;盐酸硫氮卓酮;盐酸盐地尔硫卓 标准品;(+)-顺式盐酸地尔硫
英文名称
(+)-cis-Diltiazem Hydrochloride
英文别名
Dilthiazem hydrochloride;BENZOTHIAZEPIN-4(5H)-ONE HYDROCHLORIDE;(2S,3S)-(+)-CIS-3-(ACETOXY)-5-(2-DIMETHYLAMINOETHYL)-2,3-DIHYDRO-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE, HCL;(2S-CIS)-3-(ACETYLOXY)-5-[2-(DIMETHYLAMINO)ETHYL]-2,3-DIHYDRO-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE HYDROCHLORIDE;CIS-(+)-3-(ACETYLOXY)-5-[2-(DIMETHYLAMINO)ETHYL]-2,3-DIHYDRO-2-(4-METHOXY-PHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE HYDROCHLORIDE;CRD-401;DILTIAZEM-D3 HCL;DILTIAZEM HCL;DILTIAZEM HYDROCHLORIDE;L-CIS-DILTIAZEM HCL;1,5-benzothiazepin-4(5h)-one,2,3-dihydro-3-(acetyloxy)-5-(2-(dimethylamino)eth;2,3-dihydro-3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-5-benzothiazepin-4(5h)-one;altiazem;anginyl;angizem;britiazim;bruzem;calcicard;cardizem;dilpral;(+)-cis-Diltiazem Hydrochloride;(2S,3S)-(+)-3-Acetoxy-2,3-Dihydro-5-[2-(DimEthylamino)Ethyl]-2-(4-Methoxyphenyl)-1,5-Benzothiazepin-4(5H)-One Hydrochloride;Diltiazem • HCl;Diltiazem hydrochloride solution;Adizem;Cohlen;Cormax;Diltiazem (hydrochloride);Diltiazem hydrochloride s;dilzem;Kardil;masdil;Tiazac;Zilde;Zilden;(2S,3S)-(+)-cis-3-Acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride;(+)-cis-3-(Acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)one monohydrochloride
Cas No.
33286-22-5
分子式
C22H26N2O4S.HCl
分子量
450.98
包装储存

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

生物活性

Diltiazem hydrochloride is a Ca influx inhibitor (slow channel blocker or calcium antagonist).

性状

Solid

体外研究(In Vitro)

Benzothiazepine Ca antagonist diltiazem hydrochloride interacts with transmembrane segments IIIS6 and IVS6 in the α1 subunit of L-type Ca channels. Diltiazem causes a dose-dependent inhibiton of contractions as well as Ca influx stimulated by alpha adrenoceptor activation and high-K depolarization. Diltiazem is roughly equally potent in inhibiting contractions induced by high-K and a low concentration of norepinephrine (NE). Diltiazem also inhibits the Na-dependent Ca-efflux from heart mitochondria. Both the (+)-optical isomers of the cis- and trans-forms of diltiazem inhibit Na-Ca exchange activity with comparable potency (IC50 of 10-20 μM).

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Diltiazem produces a noncompetitive inhibition of Ca-induced contractions of depolarized rabbit aorta. Furthermore, there is a lack of parallelism between the smooth muscle effects of removal of [Ca]ex and of addition of diltiazem. Diltiazem improves the cardiac microcirculation and function in an experimental model of hyperthyroidism in rats. The treatment of hyperthyroid rats with losartan diltiazem (4.7±0.7%; P < 0.001) significantly reduces the percentage of fibrosis areas in the left ventricle . In conscious spontaneously hypertensive rats (SHR), diltiazem dose-dependently decreases the blood pressure and increases the heart rate after intravenous administration (0.03--1 mg/kg). Oral administration of diltiazem (100 mg/kg) also reduces the blood pressure of SHR.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature or refrigerated transportation.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

ClinicalTrial
参考文献
溶解度数据
体外研究: 

H2O : 33.33 mg/mL (73.91 mM; Need ultrasonic)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.2174 mL 11.0870 mL 22.1739 mL
5 mM 0.4435 mL 2.2174 mL 4.4348 mL
10 mM 0.2217 mL 1.1087 mL 2.2174 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: PBS

    Solubility: 100 mg/mL (221.74 mM); Clear solution; Need ultrasonic

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2